| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |